Indchemie Health Specialities Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 38 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.35 Cr
- Satisfied Charges ₹ 30.21 Cr
- Revenue Growth 8.50%
- Profit Growth -24.14%
- Ebitda 51.91%
- Net Worth 4.85%
- Total Assets 12.90%
About Indchemie Health Specialities
Indchemie Health Specialities Private Limited (IHSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 April 1986 and has a history of 38 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹7.35 Cr. The company has closed loans amounting to ₹30.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gautam Parekh, Mritunjay Singh, Abhay Sinha, and Two other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1986PTC039692
- Company No.
039692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 1986
- Date of AGM
05 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Indchemie Health Specialities Private Limited offer?
Indchemie Health Specialities Private Limited offers a wide range of products and services, including Health Conditions, Bone, Joint & Muscle Care, Women Care, Women Care Supplements, Mother Care.
Who are the key members and board of directors at Indchemie Health Specialities?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mritunjay Singh ![]() | Managing Director | 02-Nov-2002 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gautam Parekh ![]() | Director | 20-Jul-2015 | Current |
Abhay Sinha ![]() | Director | 27-Apr-2009 | Current |
Akhouri Prasad ![]() | Director | 20-Jul-2015 | Current |
Anand Ramaswamy ![]() | Whole-Time Director | 13-Apr-2018 | Current |
Financial Performance of Indchemie Health Specialities.
Indchemie Health Specialities Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.5% increase. The company also saw a substantial fall in profitability, with a 24.14% decrease in profit. The company's net worth moved up by a moderate rise of 4.85%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Indchemie Health Specialities?
In 2023, Indchemie Health Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹73.45 M
₹302.12 M
Charges Breakdown by Lending Institutions
- Others : 5.50 Cr
- The Sarasawat Co-Op. Bank .Ltd. : 1.00 Cr
- Bank Of India : 0.35 Cr
- Member Secretary Single Window Clearance Agency : 0.30 Cr
- Devlopment Co-Operative Bank Ltd. : 0.20 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Jul 2008 | Member Secretary Single Window Clearance Agency | ₹3.00 M | Open |
15 Mar 2003 | The Sarasawat Co-Op. Bank .Ltd. | ₹1.00 Cr | Open |
25 Nov 1997 | Others | ₹5.50 Cr | Open |
03 Feb 1987 | Bank Of India | ₹3.45 M | Open |
08 Sep 1986 | Devlopment Co-Operative Bank Ltd. | ₹2.00 M | Open |
How Many Employees Work at Indchemie Health Specialities?
Indchemie Health Specialities has a workforce of 4258 employees as of Sep 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Indchemie Health Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indchemie Health Specialities's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.